VEGFC and neoplasm: NO induces the proliferation of lymphatic endothelial cells and prolongs their survival by increasing lymphangiogenic growth factors (e.g., VEGF-C/VEGF-D) and VEGFR-2/VEGFR-3 expression in tumor-associated lymphatic vessels [8].